BiomX

Phage therapy

Ness Ziona, Israel · Founded 2015 · $56.0M raised

Headquarters
Ness Ziona
Employees
51–200
Founded
2015
Business Model
B2B
Website
biomx.com
Total Funding
$56.0M
Last Round
$32.0M Series BFeb 2019
Rounds
2

About

Clinical‑stage company developing natural and engineered bacteriophage cocktails and personalized phage therapies to target harmful bacteria in chronic diseases.

Summary

BiomX is a Biotech company based in Ness Ziona, Israel, founded in 2015. It has raised $56.0M in total across 2 rounds, most recently a $32.0M Series B round in Feb 2019. Investors include Deerfield Management, OrbiMed and Johnson & Johnson Innovation.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Debt FinancingSeries Y Convertible Preferred StockDec 2025
$3.0M

Sign up to see all 4 rounds

Series A through Debt Financing — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BiomX on Indexed.vc
<a href="https://indexed.vc/companies/biomx"><img src="https://indexed.vc/api/badge/company/biomx" alt="BiomX on Indexed.vc" width="260" height="76" /></a>